在3月20日下午召开的业绩说明会上，公司首席执行长谢承润透露，未来三年公司将进入创新成果收获的爆发期，近20款创新产品有望获批上市，涵盖双抗、ADC（抗体药物偶联物）等前沿疗法。预计到2027年，公司创新产品数量将突破30个。

Arrested for sexually harassing a Bangladeshi university student, Asif Sardar Arnab was soon released — greeted by a cheering ...

The judiciary of Bangladesh is heavily loaded with negative tags including of high backlogs, severe delays, huge costs, ...

This recall involves all BD Vision Harnesses. This lightweight harness is designed for technical alpine and ice climbs. All ...